13.24
price down icon0.75%   -0.075
 
loading
Precedente Chiudi:
$13.32
Aprire:
$13.3
Volume 24 ore:
384.19K
Relative Volume:
0.21
Capitalizzazione di mercato:
$1.62B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.9346
EPS:
-1.91
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
-6.37%
1M Prestazione:
-13.99%
6M Prestazione:
-44.80%
1 anno Prestazione:
-69.12%
Intervallo 1D:
Value
$13.02
$13.35
Intervallo di 1 settimana:
Value
$12.95
$14.07
Portata 52W:
Value
$12.95
$57.90

10 X Genomics Inc Stock (TXG) Company Profile

Name
Nome
10 X Genomics Inc
Name
Telefono
(925) 401-7300
Name
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Dipendente
1,259
Name
Cinguettio
@10xgenomics
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
TXG's Discussions on Twitter

Confronta TXG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
TXG 13.22 1.62B 631.73M -239.78M -33.45M -1.91
VEEV 213.87 33.92B 2.57B 615.26M 996.76M 3.32
SOLV 69.78 11.55B 8.25B 404.00M 1.52B 0.00
DOCS 48.95 9.32B 493.63M 160.55M 162.20M 0.55
TEM 54.16 9.04B 640.44M -743.28M -206.93M 0.00
HQY 103.44 8.87B 1.10B 105.67M -197.98M 0.1475

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-03 Iniziato Leerink Partners Outperform
2024-07-22 Aggiornamento Jefferies Hold → Buy
2024-07-18 Downgrade JP Morgan Overweight → Neutral
2024-07-10 Downgrade Deutsche Bank Buy → Hold
2024-06-27 Downgrade Wolfe Research Outperform → Peer Perform
2024-06-25 Downgrade Guggenheim Buy → Neutral
2024-06-03 Ripresa Jefferies Hold
2024-05-01 Downgrade TD Cowen Buy → Hold
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-12-12 Aggiornamento BofA Securities Underperform → Neutral
2023-07-05 Ripresa JP Morgan Overweight
2023-05-10 Iniziato Barclays Overweight
2023-03-31 Iniziato Stephens Overweight
2023-02-02 Iniziato UBS Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-08-18 Downgrade Goldman Neutral → Sell
2022-07-25 Iniziato Canaccord Genuity Buy
2022-07-15 Downgrade BofA Securities Neutral → Underperform
2022-07-15 Downgrade William Blair Outperform → Mkt Perform
2021-10-15 Ripresa Cowen Outperform
2021-09-14 Downgrade BofA Securities Buy → Neutral
2021-03-15 Iniziato William Blair Outperform
2020-12-02 Iniziato Goldman Neutral
2020-09-09 Iniziato Morgan Stanley Overweight
2020-07-10 Iniziato Stifel Buy
2020-03-05 Iniziato Guggenheim Buy
2020-01-07 Iniziato Citigroup Buy
2019-10-07 Iniziato BofA/Merrill Buy
2019-10-07 Iniziato Cowen Outperform
2019-10-07 Iniziato JP Morgan Overweight
2019-09-24 Iniziato Evercore ISI Outperform
Mostra tutto

10 X Genomics Inc Borsa (TXG) Ultime notizie

pulisher
09:07 AM

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Brown Capital Management LLC - MarketBeat

09:07 AM
pulisher
Nov 20, 2024

10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay Workflows - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

10 Best Genomics Stocks To Buy Right Now - Insider Monkey

Nov 20, 2024
pulisher
Nov 19, 2024

10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

LMR Partners LLP Invests $1.59 Million in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 19, 2024
pulisher
Nov 15, 2024

10X Genomics stock hits 52-week low at $13.98 amid market shifts - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

10x Genomics (NASDAQ:TXG) Hits New 52-Week LowWhat's Next? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Relative Strength Alert For 10x Genomics - Nasdaq

Nov 14, 2024
pulisher
Nov 14, 2024

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

10X Genomics' SWOT analysis: genomics firm's stock faces headwinds, eyes recovery - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Sumitomo Mitsui Trust Group Inc. Grows Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Nikko Asset Management Americas, Inc. Expands Stake in 10x Genomics Inc. - GuruFocus.com

Nov 09, 2024
pulisher
Nov 08, 2024

TXG10x Genomics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference - BioSpace

Nov 08, 2024
pulisher
Nov 08, 2024

ARK Investment Management LLC Purchases 1,436,582 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference – Company Announcement - Financial Times

Nov 07, 2024
pulisher
Nov 05, 2024

10x Genomics Announces Preliminary Select Third Quarter 2024 Res - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

10x Genomics Reports Third Quarter 2024 Financial Results - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

10x Genomics Announces Mega-Scale Single Cell Analysis for One C - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Sumitomo Mitsui Trust Group's Strategic Acquisition in 10x Genomics Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

10x Genomics Inc (TXG) Trading 2.45% Higher on Nov 4 - GuruFocus.com

Nov 04, 2024
pulisher
Nov 01, 2024

Barclays Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Brokers Set Expectations for 10x Genomics FY2024 Earnings - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Allspring Global Investments Holdings LLC Has $880,000 Stake in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative - PR Newswire

Oct 31, 2024
pulisher
Oct 31, 2024

10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Trading 4.91% Higher on Oct 30 - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Citigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $23.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Canaccord keeps 10X Genomics shares at Buy list - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics (NASDAQ:TXG) Issues Earnings Results - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics Reports Mixed Q3 2024 Results - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics: Q3 Earnings Snapshot - The Advocate

Oct 30, 2024
pulisher
Oct 30, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook - Investing.com

Oct 30, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics falls 7% on 2024 revenue guidance cut - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Inc Reports Q3 2024 Revenue of $151.7 Million, Missing Estimates; Gross Margin Improves to 70% - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics shares sink 7% on revenue miss, lowered outlook By Investing.com - Investing.com UK

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

10x Genomics Reports Third Quarter 2024 Financial Results – Company Announcement - Financial Times

Oct 29, 2024
pulisher
Oct 29, 2024

Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell - Yahoo Finance

Oct 29, 2024
pulisher
Oct 24, 2024

10X Genomics' SWOT analysis: stock faces headwinds amid strong consumables demand - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Lecap Asset Management Ltd. Purchases Shares of 38,829 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

10x Genomics (TXG) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Oct 23, 2024
pulisher
Oct 22, 2024

PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program - StockTitan

Oct 22, 2024

10 X Genomics Inc Azioni (TXG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

10 X Genomics Inc Azioni (TXG) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Hindson Benjamin J.
See Remarks
Aug 22 '24
Sale
22.53
4,351
98,027
345,704
McAnear Justin J.
Former Chief Financial Officer
Aug 22 '24
Sale
22.53
2,961
66,710
143,242
$42.31
price down icon 0.55%
$22.23
price up icon 0.22%
$20.69
price down icon 0.05%
$18.85
price up icon 0.24%
health_information_services WAY
$30.91
price down icon 0.42%
health_information_services HQY
$103.30
price up icon 0.35%
Capitalizzazione:     |  Volume (24 ore):